2013-02-28 08:21:37 - The total number of medical tourists visiting Asia is anticipated to grow at a CAGR of nearly 16% during 2010-2013, says RNCOS in its latest research report.
Growing market for medical tourism is providing a new dimension to the Asia-Pacific region’s Pharmaceutical Industry. Low costs, quality treatment, and less waiting is driving the region’s pharma sector to new heights. The region’s medical tourism is going through a transitional phase and has immense future growth and development potential. Moreover, the total number of medical tourists visiting Asia is anticipated to grow at a CAGR of nearly 16% during 2010-2013.
As per our research report, “Asia Pacific Pharma Sector Analysis”, the market growth in the region will mainly be driven by factors, like changing regulatory environment, increasing disposable incomes, rising prevalence of lifestyle diseases, and significant developments in the field of contract manufacturing, particularly in APIs. On studying the pharmaceutical
market in each country, we observed that mature markets, such as Japan and Australia are experiencing slower growth rates, while emerging as new market leaders, China and India are enjoying investments by foreign pharmaceutical companies. South Korea and New Zealand are relatively small markets, with the growth limited by the size of these island nations. We have also studied the market scenario in Indonesia, Thailand, the Philippines, Malaysia and Vietnam.
The report also finds why the Asia-Pacific region is emerging as a new destination for the generic drugs industry. As per our findings, the western countries face the issue of poorly defined regulatory pathways, and a few Asian countries are well positioned to benefit from these changes, attracting huge investments by generic companies. The OTC sector in the region has also been expanding rapidly. Further, the report provides an in-depth information about regulatory environment and key market players in each country. For the purpose of the report we have considered following countries in the Asia-Pacific region: Japan, China, India, South Korea, Malaysia, Thailand, Indonesia, Vietnam, Philippines, Australia, and New Zealand. This way, our research work aims at presenting a fair picture of the industry to clients.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM226.htm
Some of our Related Reports are:
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally (http://www.rncos.com/Report/IM081.htm)
- Booming Clinical Trials Market in India (http://www.rncos.com/Report/IM564.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.